Screener
Kestra Medical Technologies KMTS Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Kestra Medical Technologies in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 5:16 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001193125-26-303397
| Line item | April 30, 2026 | April 30, 2025 |
|---|---|---|
| Total liabilities | 98,807 | 90,338 |
| Commitments and contingencies (Note 14) | ||
| Shareholders’ equity | ||
| Common Shares, $1.00 par value; 100,000,000 shares authorized as of April 30, 2026 and April 30, 2025; 58,383,924 issued and outstanding as of April 30, 2026 and 51,348,656 shares issued and outstanding as of April 30, 2025 | 58,384 | 51,349 |
| Additional paid-in capital | 853,353 | 674,306 |
| Accumulated other comprehensive loss | (218) | — |
| Accumulated deficit | (651,861) | (520,249) |
| Total shareholders’ equity | 259,658 | 205,406 |
Item 16. Form 10-K Summary.
FAQ
- What is Kestra Medical Technologies's common stock?
- Kestra Medical Technologies (KMTS) reported common stock of $58.38M in Q1 2026.
- How has Kestra Medical Technologies's common stock changed year-over-year?
- Kestra Medical Technologies's common stock increased by 13.7% year-over-year, from $51.35M to $58.38M.
- What is the long-term trend for Kestra Medical Technologies's common stock?
- Over 2 years (2024 to 2026), Kestra Medical Technologies's common stock has grown at a 71.2% compound annual growth rate (CAGR), from $19.91M to $58.38M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Kestra Medical Technologies's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude